Frontiers in Cardiovascular Science Archived Talks
2014
Cardioprotection: A Tale of Two Mechanisms
Joseph Hill, MD, PhD
The James T. Willerson, MD, Distinguished Chair in Cardiovascular Diseases
Frank M. Ryburn Jr.
Chair in Heart Research
December 9, 2014
The Signal and the Noise: Predicting Atrial Fibrillation and Stroke Using Big Data Approaches -- Implications for Mobile Health and Wearable Tech
Mintu Turakhia, MD, MAS
Assistant Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy at the Palo Alto Veterans Affairs Health Care System
November 25, 2014
The Changing Epidemiology of Atrial Fibrillation and Stroke: Is it a Vascular Disease
Bernard J. Gersh, J MB, ChB, Dphil, FACC
November 11, 2014
Cardiac iPSCs for Disease Modeling and Drug Discovery
Joseph Wu, MD, PhD
Professor of Medicine (Cardiology) and Radiology, Stanford University
Director of the Stanford Cardiovascular Institute
November 4, 2014
Ultrasound Molecular Imaging in Cardiovascular Medicine and Drug Development
Jonathan R. Lindner, MD
M. Lowell Edwards Professor of Cardiology Knight Cardiovascular Institute, Oregon Health & Science University
October 21, 2014
Cardiovascular Research: Challenges and Opportunities Locally and Globally
Kenneth Mahaffey, MD
Vice Chair of Clinical Research, Department of Medicine; Professor of Medicine (Cardiovascular Medicine) Stanford
October 7, 2014
Experiences in Drug Discovery
Roy Vagelos, MD
Chairman of the Board, Regeneron Pharmaceuticals
Retired Chairman and Chief Executive Officer of Merck & Co.
September 23, 2014
A Case for Microvascular Pathology in Chronic Right Ventricular Failure
Norbert Voelkel, MD
Professor (Affiliate), School of Pharmacy, Virginia Commonwealth University
September 16, 2014